Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756432 | SCV000884250 | pathogenic | not provided | 2018-02-05 | criteria provided, single submitter | clinical testing | The NF1 c.5938delA; p.Thr1980fs (NM_000267.3: c.5875delA; p.Thr1959fs) variant, to our knowledge, is not reported in the medical literature or in gene-specific databases. This variant is absent from the general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant causes a frameshift by deleting a single nucleotide, and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on the above information, this variant is considered pathogenic. |
Labcorp Genetics |
RCV003598001 | SCV004423834 | pathogenic | Neurofibromatosis, type 1 | 2023-01-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr1959Glnfs*2) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 618250). For these reasons, this variant has been classified as Pathogenic. |